Financial Enhancement Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.09M | Buy |
|
|||||
|
2025
Q2 | $943K | Buy |
|
|||||
|
2025
Q1 | $864K | Buy |
|
|||||
|
2024
Q4 | $851K | Buy |
|
|||||
|
2024
Q3 | $573K | Sell |
|
|||||
|
2024
Q2 | $831K | Buy |
|
|||||
|
2024
Q1 | $722K | Buy |
|
|||||
|
2023
Q4 | $715K | Buy |
|
|||||
|
2023
Q3 | $580K | Buy |
|
|||||
|
2023
Q2 | $597K | Buy |
|
|||||
|
2023
Q1 | $573K | Sell |
|
|||||
|
2022
Q4 | $603K | Sell |
|
|||||
|
2022
Q3 | $496K | Buy |
|
|||||
|
2022
Q2 | $490K | Buy |
|
|||||
|
2022
Q1 | $279K | Buy |
|
|||||
|
2021
Q4 | $294K | Buy |
|
|||||
|
2021
Q3 | $271K | Buy |
|
|||||
|
2021
Q2 | $252K | Buy |
|
|||||
|
2021
Q1 | $215K | Buy |
|
|||||
|
2020
Q4 | $224K | Buy |
|
|||||
|
2020
Q3 | $210K | Sell |
|
|||||
|
2020
Q2 | $227K | Buy |
|
|||||
|
2020
Q1 | $175K | Buy |
|
|||||
|
2019
Q4 | $3K | Sell |
|
|||||
|
2019
Q3 | $6K | Sell |
|
|||||
|
2019
Q2 | $4.58M | Buy |
|
|||||
|
2019
Q1 | $3.72M | Sell |
|
|||||
|
2018
Q4 | $6.9M | Buy |
|
|||||
|
2018
Q3 | $6.89M | Buy |
|
|||||
|
2018
Q2 | $5.8M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $4.64M | Buy |
|
|||||
|
2016
Q3 | $326K | Sell |
|
|||||
|
2016
Q2 | $350K | Sell |
|
|||||
|
2016
Q1 | $633K | Sell |
|
|||||
|
2015
Q4 | $837K | Sell |
|
|||||
|
2015
Q3 | $781K | Sell |
|
|||||
|
2015
Q2 | $3.73M | Buy |
|